WuXi Biologics (Cayman)
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has WuXi Biologics (Cayman)'s balance sheet done over the years? Its assets were worth $56,575,726,000 last year, which is more than in the previous period. 22% of WuXi Biologics (Cayman)’s total assets is currently financed by debt. Its liabilities reached the amount of $12,557,844,000, which means an decrease by -6% compared compared to last year.
Debt to Assets
| 2014 | 636670000 | 264.84M | 41.6% |
|---|---|---|---|
| 2015 | 1356716000 | 1.21B | 89.24% |
| 2016 | 1984996000 | 1.71B | 86.37% |
| 2017 | 4848962000 | 824.60M | 17.01% |
| 2018 | 9393150000 | 1.39B | 14.89% |
| 2019 | 17602269000 | 4.70B | 26.74% |
| 2020 | 28963613000 | 8.06B | 27.84% |
| 2021 | 44032623000 | 11.32B | 25.72% |
| 2022 | 49564385000 | 13.35B | 26.94% |
| 2023 | 56575726000 | 12.55B | 22.2% |
WXXWY Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 9.66B | 6.39B | 9.00B | 7.09B | 6.20B | 4.08B | 503.88M | 169.10M | 158.22M | 5.94M |
Short term investments | 1.57B | 304.46M | 1.14B | 1.27B | 458M | 0 | 914.78M | 0 | 0 | 0 |
Net receivables | 6.18B | 5.15B | 3.27B | 2.37B | 1.37B | 798.88M | 314.30M | 293.86M | 190.31M | 130.58M |
Inventory | 1.76B | 2.28B | 1.68B | 1.08B | 399.38M | 227.18M | 337.93M | 201.69M | 49.91M | 33.55M |
Other current assets | 2.00B | 4.33B | 4.41B | 2.38B | 1.23B | 634.72M | 321.18M | 165.19M | 102.02M | 30.77M |
Total current assets | 21.19B | 18.46B | 19.52B | 14.20B | 9.67B | 5.74B | 3.03B | 829.85M | 601.11M | 229.15M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 29.93B | 25.91B | 19.75B | 12.87B | 6.79B | 2.90B | 1.78B | 1.15B | 753.99M | 404.84M |
Goodwill | 1.52B | 1.52B | 1.52B | 185.40M | 185.40M | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 511.83M | 548.77M | 600.65M | 391.85M | 415.84M | 331.81M | 0 | 0 | 0 | 0 |
Long term investments | 2.93B | 2.70B | 2.20B | 1.07B | 452.16M | 192.27M | 0 | 0 | 0 | 0 |
Other non-current assets | 461.97M | -222.56M | -220.78M | -80.13M | -36.04M | -22.48M | -6.85M | -1.15B | 0 | 0 |
Total non-current assets | 35.37B | 30.70B | 24.08B | 14.52B | 7.84B | 3.42B | 1.78B | 1.15B | 755.60M | 407.51M |
Total assets | 56.57B | 49.56B | 44.03B | 28.96B | 17.60B | 9.39B | 4.84B | 1.98B | 1.35B | 636.67M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | -1.47B | -2.22B | -827.83M | -532.59M | 0 | 0 | 0 | 0 | 0 |
Short term debt | 731.30M | 1.47B | 2.22B | 827.83M | 532.59M | 0 | 0 | 0 | 455.85M | 55.41M |
Total current liabilities | 7.63B | 9.31B | 8.25B | 4.49B | 2.87B | 1.31B | 798.07M | 800.82M | 1.20B | 260.89M |
| Non-current liabilities: | ||||||||||
Long term debt | 3.83B | 1.46B | 640.51M | 1.83B | 1.39B | 0 | 0 | 866M | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 0 | -1.08B | -1.00B | -1.05B | -173.61M | 77K | 0 | -866M | 0 | 0 |
Total non-current liabilities | 4.92B | 1.46B | 640.51M | 1.83B | 1.39B | 80.16M | 26.52M | 866M | 8.78M | 3.94M |
Total liabilities | 12.55B | 13.35B | 11.32B | 8.06B | 4.70B | 1.39B | 824.60M | 1.71B | 1.21B | 264.84M |